Universal-Beteiligungs- und Servicegesellschaft’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97M Sell
41,827
-102,276
-71% -$6.69M ﹤0.01% 1144
2026
Q1
$9.75M Buy
144,103
+106,269
+281% +$6.02M 0.02% 612
2025
Q4
$1.57M Buy
37,834
+32,607
+624% +$1.35M ﹤0.01% 1339
2025
Q3
$211K Buy
+5,227
New +$152K ﹤0.01% 1997

Other funds holding CGON

Universal-Beteiligungs- und Servicegesellschaft's CGON Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its CG Oncology (CGON) stake by 71% in Q2 2026, selling an estimated $6.69M and leaving 41,827 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.75M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 41,827 shares of CG Oncology worth $2.97M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 102,276 CG Oncology shares in Q2 2026, an estimated $6.69M.
  • CG Oncology made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1144 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's CG Oncology position peaked at $9.75M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.